AccuMetab™ Human Control Membrane Fraction

CAT#: ITS-0426-YL102
Product Type: Control Fraction
Brand: AccuMetab
Development Stage: ADME
ADME Research Domain: Metabolism
Short Description
Zero-background membrane control for accurate ADME assay baseline validation.
Brand
AccuMetab
Development Stage
ADME
ADME Research Domain
Metabolism
Background
This control fraction consists of native E. coli membranes lacking any recombinant human Phase I enzyme expression. It is a mandatory negative control in ADME assays used to establish definitive assay baselines, quantify non-specific binding, and validate that observed clearance is strictly enzyme-mediated.
Key Features
Native E. coli matrix lacking recombinant Phase I enzymes; Absolute zero-background baseline for specific assay validation; Strictly quantifies non-specific Phase I drug binding; Mandatory negative control for rigorous ADME protocols
Applications
Background Subtraction, Assay Control
Research Areas
ADME; Assay Control
Expression System
E. coli host membrane fraction preparations.
Physical Form
Liquid
Size
0.5 nmol; 1 nmol; 4 nmol; 10 mg
Storage
-80°C
Storage Comment
When stored at -80°C, our product remains stable and retains full functional activity for up to 10 years.
Note
For bulk pricing or custom reagent inquiries, please contact us by email or phone. Products are shipped on ice via FedEx.
Restrictions
For Research Use Only (RUO). Not intended for diagnostic or therapeutic use.
Shipping
Our enzyme products are shipped at -80°C.
For Research Use Only | Not For Clinical Use
Online Inquiry